Discover how a major study reveals limited fasciectomy outperforms collagenase injections for treating Dupuytren’s ...

In this randomized controlled trial, among patients with moderate Dupuytren’s contracture, collagenase injection was not ...

They mainly studied the significant role of manganese-based oxidase nanozyme (MnN) in stitching collagen, a vital structural ...

The research extends the functional capabilities of nanozymes, shifting the focus from small molecule substrates to complex ...

End; Phase 3 Study to Begin Shortly Thereafter; KOL Event Set for January 8, 2025 FDA Approves NexoBrid for Pediatric Use $25 Million Financing and €16.25 Million ...

MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced ...

Gpr54 deletion lowers NFATC3 and SFRP1 levels, activates the Wnt/β-catenin pathway, which stimulates DPCs and HFSCs, and ...

("Endo") (OTCQX: NDOI) announced today that John Elway will share an update about his Dupuytren's contracture patient journey, including his treatment with XIAFLEX ® (collagenase clostridium ...

Elway will speak to several media outlets on November 20, 2024 to detail his patient journey and provide an update on his current hand health. He believes he is feeling the beginning of Dupuytren's ...